Determining Asthma Severity Based on Pulmonary Function Tests (PFTs)
Asthma severity should be classified based on both lung function parameters from PFTs and clinical impairment, with FEV1 below 60% of predicted indicating severe persistent asthma regardless of symptom frequency. 1
Lung Function Parameters for Severity Classification
Intermittent Asthma: Normal FEV1 ≥80% of predicted with normal FEV1/FVC ratio 1
Mild Persistent Asthma: FEV1 ≥80% of predicted but with FEV1/FVC reduced >5% from normal 1
Moderate Persistent Asthma: FEV1 between 60-80% of predicted with FEV1/FVC reduced >5% from normal 1
Severe Persistent Asthma: FEV1 <60% of predicted with reduced FEV1/FVC ratio 1
Two-Domain Approach to Severity Assessment
Asthma severity classification incorporates two key domains that should be evaluated together 1, 2:
Impairment Domain:
- Objective PFT measurements (FEV1 and FEV1/FVC ratio)
- Symptom frequency and intensity
- Nighttime awakenings
- Short-acting beta-agonist use
- Activity limitation 1
Risk Domain:
Important Considerations When Using PFTs
The final severity classification should be guided by the most severe category in which any feature of impairment or risk occurs 1
Normal FEV1/FVC ratios vary by age: 85% for ages 8-19 years, 80% for ages 20-39 years, 75% for ages 40-59 years, and 70% for ages 60-80 years 1
Bronchodilator responsiveness testing (showing ≥12% and ≥200 mL improvement in FEV1 after bronchodilator) is valuable for both diagnosis and severity assessment 1
Variability in PEF measurements ≥20% over time is diagnostic of asthma and helps determine severity 3
Clinical Application
Ideally, severity classification should be determined before initiating therapy, as treatment may mask the true severity 1
For patients already on treatment, assessment of control rather than severity becomes more relevant for ongoing management 4
The classification of asthma severity is not a static feature and may change over months or years, requiring periodic reassessment 4
Common Pitfalls to Avoid
Relying solely on symptoms without objective PFT measurements can lead to misclassification of severity 1, 3
Failing to consider exacerbation history when classifying severity may result in undertreating patients with frequent exacerbations despite good lung function 1, 2
Not accounting for age-related changes in normal FEV1/FVC ratios can lead to misclassification 1
Assessing severity during an acute exacerbation rather than during a stable period may overestimate the baseline severity 1